As the a result of these reforms, the United States may once again become the jurisdiction of choice for both domestic and non-U.S. companies contemplating an IPO.
The company is also on track to bring impending IPO of its animal unit Zoetis as part of its strategy to focus on non-core assets and we will look for updates on the progress.